WORLD
Bluebird's $2.8 Million Gene Therapy Becomes Most Expensive Drug After U.S. Approval - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Bluebird's $2.8 million gene therapy becomes most expensive drug after U.S. approval ...'
Bluebird's $2.8 million gene therapy becomes most expensive drug after U.S. approval https://t.co/7oRIqqvhxE pic.twitter.com/MkZvtiP5Jn— Reuters (@Reuters) August 18, 2022
(The above story first appeared on LatestLY on Aug 18, 2022 08:54 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
